Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00716443 · ClinicalTrials.gov registry record · Phase 4
Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections
A Phase 4 study, sponsored by Galderma R&D.
- Terminated
- Registry status
- Phase 4
- Development phase
- 51
- Enrollment target
NCT00716443 is a Phase 4 study that was terminated before completion, run by Galderma R&D. The registered enrollment target is 51 participants.
The verdict
NCT00716443, a Phase 4 study, was terminated before completion, sponsored by Galderma R&D.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 51 participants
- Enrollment target
Study Summary
Pliaglis® Cream versus compounded topical anesthetic for pain management during Restylane® injections for the correction of nasolabial folds.
Interventions
- DRUG tetracaine 7% / lidocaine 7% cream (Pliaglis® Cream)
- DRUG benzocaine 20% / lidocaine 6% / tetracaine 4% ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2008-07 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00716443
The ClinicalTrials.gov registry entry for NCT00716443 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tetracaine 7% / lidocaine 7% cream (Pliaglis® Cream) is the first listed.
NCT00716443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00716443 about?
NCT00716443 is a clinical study titled "Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections". Pliaglis® Cream versus compounded topical anesthetic for pain management during Restylane® injections for the correction of nasolabial folds.
What is the current status of trial NCT00716443?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2008-07. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00716443?
The interventions under investigation include: tetracaine 7% / lidocaine 7% cream (Pliaglis® Cream) (DRUG), benzocaine 20% / lidocaine 6% / tetracaine 4% ointment (DRUG).
Who is sponsoring clinical trial NCT00716443?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.